Gene Symbol | Gene ID | Gene Info |
---|---|---|
E2F8
|
ENSG00000129173.8 | E2F transcription factor 8 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_19261961_19262230 | E2F8 | 403 | 0.857430 | 0.60 | 8.5e-02 | Click! |
chr11_19305428_19305803 | E2F8 | 42448 | 0.135442 | 0.58 | 1.0e-01 | Click! |
chr11_19298540_19298691 | E2F8 | 35448 | 0.152214 | -0.52 | 1.5e-01 | Click! |
chr11_19254592_19254743 | E2F8 | 7831 | 0.193574 | -0.49 | 1.8e-01 | Click! |
chr11_19266201_19266355 | E2F8 | 3111 | 0.262131 | -0.47 | 2.0e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_92138368_92138605 | 0.48 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
25441 |
0.19 |
chr6_24920336_24920683 | 0.46 |
FAM65B |
family with sequence similarity 65, member B |
9314 |
0.23 |
chr8_95941718_95941912 | 0.46 |
TP53INP1 |
tumor protein p53 inducible nuclear protein 1 |
11386 |
0.13 |
chr11_48041048_48041486 | 0.44 |
AC103828.1 |
|
3860 |
0.26 |
chr11_74987512_74987913 | 0.44 |
ARRB1 |
arrestin, beta 1 |
2031 |
0.24 |
chr13_52396732_52397247 | 0.42 |
RP11-327P2.5 |
|
18556 |
0.18 |
chr4_185150814_185151001 | 0.41 |
ENPP6 |
ectonucleotide pyrophosphatase/phosphodiesterase 6 |
8524 |
0.22 |
chr6_15246484_15246635 | 0.40 |
JARID2 |
jumonji, AT rich interactive domain 2 |
32 |
0.98 |
chr2_205831873_205832072 | 0.39 |
PARD3B |
par-3 family cell polarity regulator beta |
421249 |
0.01 |
chr15_75900898_75901062 | 0.39 |
SNUPN |
snurportin 1 |
8885 |
0.11 |
chr17_25784455_25784823 | 0.39 |
KSR1 |
kinase suppressor of ras 1 |
899 |
0.6 |
chr9_140345198_140345349 | 0.39 |
NSMF |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
3671 |
0.14 |
chr16_4316350_4316501 | 0.38 |
TFAP4 |
transcription factor AP-4 (activating enhancer binding protein 4) |
2687 |
0.23 |
chr14_100560569_100560771 | 0.38 |
EVL |
Enah/Vasp-like |
2614 |
0.2 |
chr2_241342781_241342932 | 0.38 |
GPC1 |
glypican 1 |
32232 |
0.15 |
chr12_21766695_21766846 | 0.37 |
GYS2 |
glycogen synthase 2 (liver) |
8989 |
0.2 |
chr17_61780107_61780446 | 0.37 |
STRADA |
STE20-related kinase adaptor alpha |
1539 |
0.28 |
chr22_37620705_37620902 | 0.37 |
SSTR3 |
somatostatin receptor 3 |
12441 |
0.13 |
chr1_200994706_200994917 | 0.37 |
KIF21B |
kinesin family member 21B |
1983 |
0.32 |
chr19_16960816_16960967 | 0.37 |
CTD-2538G9.5 |
|
6055 |
0.13 |
chr20_32446812_32447014 | 0.37 |
CHMP4B |
charged multivesicular body protein 4B |
47803 |
0.12 |
chr1_154438061_154438451 | 0.36 |
RP11-350G8.9 |
|
14232 |
0.12 |
chr5_169703034_169703822 | 0.36 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
9097 |
0.23 |
chr1_206940002_206940347 | 0.36 |
IL10 |
interleukin 10 |
5665 |
0.17 |
chr3_101774516_101774796 | 0.35 |
ZPLD1 |
zona pellucida-like domain containing 1 |
43432 |
0.18 |
chrX_38529055_38529246 | 0.35 |
ENSG00000238606 |
. |
61682 |
0.13 |
chr7_56118702_56118950 | 0.35 |
PSPH |
phosphoserine phosphatase |
155 |
0.79 |
chr14_22973101_22973316 | 0.35 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
17037 |
0.09 |
chr1_153848148_153848299 | 0.34 |
GATAD2B |
GATA zinc finger domain containing 2B |
47228 |
0.08 |
chr5_130710388_130710539 | 0.34 |
CDC42SE2 |
CDC42 small effector 2 |
10836 |
0.3 |
chr22_17700910_17701256 | 0.34 |
CECR1 |
cat eye syndrome chromosome region, candidate 1 |
758 |
0.68 |
chr9_271617_272065 | 0.34 |
RP11-59O6.3 |
|
1161 |
0.37 |
chr2_175315188_175315339 | 0.34 |
GPR155 |
G protein-coupled receptor 155 |
36502 |
0.14 |
chr1_212209141_212209453 | 0.33 |
DTL |
denticleless E3 ubiquitin protein ligase homolog (Drosophila) |
205 |
0.71 |
chr17_66250172_66250736 | 0.33 |
AMZ2 |
archaelysin family metallopeptidase 2 |
4126 |
0.18 |
chr20_43657355_43657581 | 0.33 |
ENSG00000252021 |
. |
24479 |
0.14 |
chr18_66381488_66381790 | 0.33 |
TMX3 |
thioredoxin-related transmembrane protein 3 |
655 |
0.52 |
chr10_6549756_6549940 | 0.33 |
PRKCQ |
protein kinase C, theta |
72353 |
0.12 |
chr8_134086760_134086925 | 0.33 |
SLA |
Src-like-adaptor |
14239 |
0.23 |
chr4_4857303_4857507 | 0.33 |
MSX1 |
msh homeobox 1 |
3988 |
0.32 |
chr10_6571808_6571959 | 0.33 |
PRKCQ |
protein kinase C, theta |
50318 |
0.18 |
chr14_93159341_93159532 | 0.33 |
LGMN |
legumain |
24368 |
0.21 |
chrX_70321837_70321988 | 0.33 |
CXorf65 |
chromosome X open reading frame 65 |
4543 |
0.12 |
chr3_43388752_43388982 | 0.33 |
RP11-188P20.3 |
|
268 |
0.91 |
chr10_121334352_121334503 | 0.33 |
TIAL1 |
TIA1 cytotoxic granule-associated RNA binding protein-like 1 |
13295 |
0.21 |
chr11_118177738_118177927 | 0.32 |
CD3E |
CD3e molecule, epsilon (CD3-TCR complex) |
2218 |
0.21 |
chr5_74354344_74354509 | 0.32 |
GCNT4 |
glucosaminyl (N-acetyl) transferase 4, core 2 |
27702 |
0.23 |
chr18_13379607_13379896 | 0.32 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
2802 |
0.23 |
chr2_239402597_239402871 | 0.32 |
AC016999.2 |
|
66364 |
0.1 |
chr3_37998819_37999085 | 0.32 |
CTDSPL |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
7118 |
0.16 |
chr16_71914316_71914975 | 0.32 |
ZNF821 |
zinc finger protein 821 |
677 |
0.52 |
chr10_48481902_48482094 | 0.32 |
GDF10 |
growth differentiation factor 10 |
43022 |
0.14 |
chr1_19990632_19990980 | 0.31 |
HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
974 |
0.53 |
chr1_40308777_40308928 | 0.31 |
ENSG00000202222 |
. |
38498 |
0.09 |
chr4_39184616_39184822 | 0.31 |
WDR19 |
WD repeat domain 19 |
551 |
0.8 |
chr20_43996117_43996734 | 0.31 |
SYS1 |
SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae) |
4331 |
0.13 |
chr16_79321230_79321593 | 0.31 |
ENSG00000222244 |
. |
23060 |
0.27 |
chr15_58776881_58777054 | 0.31 |
ALDH1A2 |
aldehyde dehydrogenase 1 family, member A2 |
10855 |
0.17 |
chr16_2732054_2732296 | 0.31 |
KCTD5 |
potassium channel tetramerization domain containing 5 |
301 |
0.81 |
chr6_112311435_112311966 | 0.30 |
WISP3 |
WNT1 inducible signaling pathway protein 3 |
63575 |
0.11 |
chr15_91143361_91143512 | 0.30 |
CTD-3065B20.2 |
|
3757 |
0.19 |
chr2_29236792_29237319 | 0.30 |
FAM179A |
family with sequence similarity 179, member A |
4072 |
0.19 |
chr9_15273609_15273760 | 0.30 |
TTC39B |
tetratricopeptide repeat domain 39B |
23570 |
0.22 |
chr1_114483670_114483821 | 0.30 |
HIPK1 |
homeodomain interacting protein kinase 1 |
10022 |
0.13 |
chr1_8489234_8489385 | 0.30 |
RP5-1115A15.1 |
|
3611 |
0.23 |
chr22_31635869_31636357 | 0.30 |
LIMK2 |
LIM domain kinase 2 |
8231 |
0.11 |
chr10_3823619_3823776 | 0.30 |
KLF6 |
Kruppel-like factor 6 |
3688 |
0.26 |
chrX_51546941_51547203 | 0.30 |
MAGED1 |
melanoma antigen family D, 1 |
969 |
0.65 |
chr1_154129901_154130138 | 0.29 |
NUP210L |
nucleoporin 210kDa-like |
2427 |
0.16 |
chr2_99075660_99075918 | 0.29 |
INPP4A |
inositol polyphosphate-4-phosphatase, type I, 107kDa |
14376 |
0.23 |
chr21_37442647_37442931 | 0.29 |
CBR1 |
carbonyl reductase 1 |
456 |
0.7 |
chr17_36125147_36125495 | 0.29 |
HNF1B |
HNF1 homeobox B |
20084 |
0.17 |
chr6_11232229_11232517 | 0.29 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
518 |
0.84 |
chr7_143007723_143007933 | 0.29 |
CLCN1 |
chloride channel, voltage-sensitive 1 |
5391 |
0.1 |
chr8_28917857_28918302 | 0.29 |
CTD-2647L4.4 |
|
4627 |
0.16 |
chr17_74994699_74995052 | 0.29 |
ENSG00000267568 |
. |
29637 |
0.18 |
chr5_56029244_56029395 | 0.29 |
MAP3K1 |
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
82082 |
0.08 |
chr5_61595708_61595925 | 0.29 |
KIF2A |
kinesin heavy chain member 2A |
6173 |
0.29 |
chr1_117314006_117314157 | 0.29 |
CD2 |
CD2 molecule |
16992 |
0.21 |
chr1_172674168_172674377 | 0.28 |
FASLG |
Fas ligand (TNF superfamily, member 6) |
46114 |
0.18 |
chr1_161101761_161102002 | 0.28 |
DEDD |
death effector domain containing |
375 |
0.66 |
chr6_149805531_149805682 | 0.28 |
ZC3H12D |
zinc finger CCCH-type containing 12D |
520 |
0.75 |
chr19_19144819_19144970 | 0.28 |
ARMC6 |
armadillo repeat containing 6 |
18 |
0.53 |
chr6_154549761_154549912 | 0.28 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
18154 |
0.29 |
chr1_226917633_226918259 | 0.28 |
ITPKB |
inositol-trisphosphate 3-kinase B |
7213 |
0.24 |
chr7_37397373_37397585 | 0.28 |
ELMO1 |
engulfment and cell motility 1 |
4207 |
0.24 |
chr8_8670148_8670299 | 0.28 |
MFHAS1 |
malignant fibrous histiocytoma amplified sequence 1 |
80932 |
0.08 |
chr2_98329502_98329955 | 0.28 |
ZAP70 |
zeta-chain (TCR) associated protein kinase 70kDa |
295 |
0.89 |
chr12_67910109_67910260 | 0.28 |
DYRK2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
131934 |
0.05 |
chr1_194195076_194195457 | 0.28 |
ENSG00000251813 |
. |
262069 |
0.02 |
chr10_88853042_88853193 | 0.28 |
GLUD1 |
glutamate dehydrogenase 1 |
710 |
0.41 |
chr20_47355126_47355349 | 0.28 |
ENSG00000251876 |
. |
748 |
0.78 |
chr3_30681139_30681293 | 0.28 |
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa) |
33123 |
0.22 |
chr8_142114570_142114965 | 0.28 |
DENND3 |
DENN/MADD domain containing 3 |
12610 |
0.2 |
chr9_136542992_136543196 | 0.28 |
DBH-AS1 |
DBH antisense RNA 1 |
20659 |
0.14 |
chr5_72794880_72795057 | 0.28 |
BTF3 |
basic transcription factor 3 |
633 |
0.72 |
chrX_118809140_118809384 | 0.28 |
SEPT6 |
septin 6 |
17530 |
0.16 |
chr6_39193250_39193401 | 0.27 |
KCNK5 |
potassium channel, subfamily K, member 5 |
3901 |
0.31 |
chr1_212856444_212856782 | 0.27 |
ENSG00000207491 |
. |
8993 |
0.16 |
chr14_104855656_104855812 | 0.27 |
ENSG00000222761 |
. |
11651 |
0.26 |
chr14_91869680_91869962 | 0.27 |
CCDC88C |
coiled-coil domain containing 88C |
13869 |
0.23 |
chr16_89831901_89832100 | 0.27 |
FANCA |
Fanconi anemia, complementation group A |
20530 |
0.11 |
chr16_54317076_54317257 | 0.27 |
IRX3 |
iroquois homeobox 3 |
2601 |
0.34 |
chr11_46353424_46353814 | 0.27 |
DGKZ |
diacylglycerol kinase, zeta |
836 |
0.56 |
chrX_135226218_135226483 | 0.27 |
FHL1 |
four and a half LIM domains 1 |
3209 |
0.27 |
chr4_109057465_109057616 | 0.27 |
LEF1 |
lymphoid enhancer-binding factor 1 |
29917 |
0.19 |
chr1_28270612_28270863 | 0.27 |
SMPDL3B |
sphingomyelin phosphodiesterase, acid-like 3B |
9116 |
0.12 |
chr6_166748574_166748725 | 0.27 |
SFT2D1 |
SFT2 domain containing 1 |
7430 |
0.19 |
chr12_111116625_111116776 | 0.27 |
HVCN1 |
hydrogen voltage-gated channel 1 |
9814 |
0.17 |
chr17_33755333_33755563 | 0.27 |
SLFN12 |
schlafen family member 12 |
4095 |
0.17 |
chr13_99864611_99864762 | 0.27 |
ENSG00000201793 |
. |
6724 |
0.2 |
chr1_161158279_161158521 | 0.27 |
ADAMTS4 |
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
10443 |
0.06 |
chr15_22541894_22542172 | 0.27 |
ENSG00000221641 |
. |
28753 |
0.14 |
chr1_169667136_169667565 | 0.27 |
SELL |
selectin L |
13489 |
0.19 |
chr6_403561_403912 | 0.27 |
IRF4 |
interferon regulatory factor 4 |
11997 |
0.28 |
chr14_75714503_75714762 | 0.27 |
RP11-293M10.2 |
|
11482 |
0.15 |
chr7_157405170_157405445 | 0.27 |
AC005481.5 |
Uncharacterized protein |
1408 |
0.48 |
chr2_198027116_198027292 | 0.27 |
ANKRD44 |
ankyrin repeat domain 44 |
14576 |
0.22 |
chr12_92499837_92499988 | 0.27 |
C12orf79 |
chromosome 12 open reading frame 79 |
30885 |
0.16 |
chr1_167452616_167452767 | 0.27 |
RP11-104L21.2 |
|
24793 |
0.17 |
chr1_12124513_12125028 | 0.27 |
TNFRSF8 |
tumor necrosis factor receptor superfamily, member 8 |
1243 |
0.37 |
chr15_61134389_61134543 | 0.27 |
RP11-554D20.1 |
|
77527 |
0.11 |
chr7_8188472_8188733 | 0.27 |
ENSG00000265212 |
. |
6050 |
0.24 |
chr1_205780246_205780397 | 0.27 |
SLC41A1 |
solute carrier family 41 (magnesium transporter), member 1 |
1983 |
0.3 |
chr15_81616223_81616414 | 0.26 |
STARD5 |
StAR-related lipid transfer (START) domain containing 5 |
148 |
0.78 |
chr8_21917244_21917395 | 0.26 |
DMTN |
dematin actin binding protein |
585 |
0.63 |
chr7_150283340_150283491 | 0.26 |
GIMAP4 |
GTPase, IMAP family member 4 |
18891 |
0.17 |
chr1_37072853_37073004 | 0.26 |
CSF3R |
colony stimulating factor 3 receptor (granulocyte) |
124049 |
0.05 |
chr13_24848157_24848441 | 0.26 |
SPATA13 |
spermatogenesis associated 13 |
1472 |
0.37 |
chr4_103746866_103747017 | 0.26 |
UBE2D3 |
ubiquitin-conjugating enzyme E2D 3 |
1 |
0.97 |
chr5_89824965_89825116 | 0.26 |
GPR98 |
G protein-coupled receptor 98 |
121 |
0.77 |
chr10_134250626_134250777 | 0.26 |
RP11-432J24.3 |
|
4287 |
0.21 |
chr6_111417165_111417343 | 0.26 |
ENSG00000200926 |
. |
4719 |
0.21 |
chr2_46771170_46771438 | 0.26 |
RHOQ |
ras homolog family member Q |
765 |
0.53 |
chr7_50465139_50465290 | 0.26 |
ENSG00000200815 |
. |
37864 |
0.17 |
chr17_73284943_73285225 | 0.26 |
SLC25A19 |
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 |
209 |
0.87 |
chr5_141339545_141339774 | 0.26 |
PCDH12 |
protocadherin 12 |
1032 |
0.38 |
chr13_41575756_41575909 | 0.26 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
17618 |
0.19 |
chr1_31451236_31451387 | 0.26 |
ENSG00000200181 |
. |
10228 |
0.16 |
chr21_35009334_35009485 | 0.26 |
CRYZL1 |
crystallin, zeta (quinone reductase)-like 1 |
3401 |
0.21 |
chr18_68340939_68341090 | 0.26 |
GTSCR1 |
Gilles de la Tourette syndrome chromosome region, candidate 1 |
23034 |
0.28 |
chr7_27879709_27879984 | 0.26 |
TAX1BP1 |
Tax1 (human T-cell leukemia virus type I) binding protein 1 |
12426 |
0.23 |
chr18_55333585_55333751 | 0.26 |
ATP8B1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
22232 |
0.15 |
chr4_147097308_147097459 | 0.26 |
LSM6 |
LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
502 |
0.83 |
chr7_144517018_144517169 | 0.26 |
TPK1 |
thiamin pyrophosphokinase 1 |
16053 |
0.24 |
chr10_81009536_81009687 | 0.25 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
56364 |
0.14 |
chr14_90081515_90082105 | 0.25 |
FOXN3 |
forkhead box N3 |
3664 |
0.17 |
chr10_28622609_28622843 | 0.25 |
MPP7 |
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
689 |
0.74 |
chr14_69862004_69862155 | 0.25 |
ERH |
enhancer of rudimentary homolog (Drosophila) |
2937 |
0.27 |
chr4_96212646_96212797 | 0.25 |
BMPR1B |
bone morphogenetic protein receptor, type IB |
187215 |
0.03 |
chr8_19526433_19526584 | 0.25 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
13586 |
0.3 |
chr4_83292965_83293276 | 0.25 |
HNRNPD |
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) |
1183 |
0.42 |
chrX_78213061_78213264 | 0.25 |
P2RY10 |
purinergic receptor P2Y, G-protein coupled, 10 |
12244 |
0.31 |
chr17_18805378_18805631 | 0.25 |
PRPSAP2 |
phosphoribosyl pyrophosphate synthetase-associated protein 2 |
8963 |
0.14 |
chr17_74268830_74269044 | 0.25 |
UBALD2 |
UBA-like domain containing 2 |
7153 |
0.13 |
chr19_7060314_7060465 | 0.25 |
MBD3L3 |
methyl-CpG binding domain protein 3-like 3 |
1738 |
0.24 |
chr20_45181136_45181287 | 0.25 |
OCSTAMP |
osteoclast stimulatory transmembrane protein |
1998 |
0.35 |
chr1_65420057_65420208 | 0.25 |
JAK1 |
Janus kinase 1 |
12055 |
0.24 |
chr3_182535868_182536019 | 0.25 |
ATP11B |
ATPase, class VI, type 11B |
18962 |
0.21 |
chr8_127514447_127514598 | 0.25 |
ENSG00000207138 |
. |
2486 |
0.33 |
chr22_19492900_19493051 | 0.25 |
CLDN5 |
claudin 5 |
19931 |
0.11 |
chr1_32729687_32729990 | 0.25 |
LCK |
lymphocyte-specific protein tyrosine kinase |
9876 |
0.09 |
chr18_13415322_13415736 | 0.25 |
LDLRAD4-AS1 |
LDLRAD4 antisense RNA 1 |
11950 |
0.14 |
chr14_70092578_70092874 | 0.25 |
KIAA0247 |
KIAA0247 |
14413 |
0.23 |
chr19_52641838_52642032 | 0.25 |
ZNF616 |
zinc finger protein 616 |
143 |
0.93 |
chr1_28995908_28996059 | 0.25 |
GMEB1 |
glucocorticoid modulatory element binding protein 1 |
691 |
0.59 |
chr3_52739027_52739199 | 0.25 |
SPCS1 |
signal peptidase complex subunit 1 homolog (S. cerevisiae) |
142 |
0.81 |
chr2_109580892_109581113 | 0.25 |
EDAR |
ectodysplasin A receptor |
24723 |
0.24 |
chr11_44799482_44799633 | 0.25 |
TSPAN18 |
tetraspanin 18 |
13581 |
0.28 |
chr9_119747863_119748014 | 0.25 |
ENSG00000265662 |
. |
113348 |
0.07 |
chrX_118890897_118891053 | 0.25 |
SOWAHD |
sosondowah ankyrin repeat domain family member D |
1601 |
0.33 |
chrX_153577620_153577796 | 0.25 |
FLNA |
filamin A, alpha |
3829 |
0.12 |
chr13_100035601_100035752 | 0.25 |
ENSG00000207719 |
. |
27291 |
0.18 |
chr14_100740094_100740249 | 0.25 |
RP11-638I2.2 |
|
10053 |
0.09 |
chr2_128051406_128051557 | 0.25 |
ERCC3 |
excision repair cross-complementing rodent repair deficiency, complementation group 3 |
189 |
0.95 |
chr17_17309326_17309550 | 0.25 |
ENSG00000201741 |
. |
54320 |
0.1 |
chrX_75364693_75364987 | 0.25 |
PBDC1 |
polysaccharide biosynthesis domain containing 1 |
27931 |
0.25 |
chr5_154321291_154321511 | 0.25 |
MRPL22 |
mitochondrial ribosomal protein L22 |
739 |
0.64 |
chr1_46131645_46131796 | 0.24 |
GPBP1L1 |
GC-rich promoter binding protein 1-like 1 |
20488 |
0.13 |
chr1_66836150_66836429 | 0.24 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
16224 |
0.28 |
chrX_62973815_62974068 | 0.24 |
ARHGEF9 |
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
1047 |
0.62 |
chr17_72272476_72272627 | 0.24 |
DNAI2 |
dynein, axonemal, intermediate chain 2 |
2122 |
0.2 |
chr1_110449147_110449329 | 0.24 |
CSF1 |
colony stimulating factor 1 (macrophage) |
3626 |
0.22 |
chr11_60793831_60793982 | 0.24 |
CD6 |
CD6 molecule |
17900 |
0.14 |
chr17_76410012_76410244 | 0.24 |
PGS1 |
phosphatidylglycerophosphate synthase 1 |
10083 |
0.13 |
chr15_77295458_77295609 | 0.24 |
PSTPIP1 |
proline-serine-threonine phosphatase interacting protein 1 |
7618 |
0.2 |
chr6_131603664_131603895 | 0.24 |
AKAP7 |
A kinase (PRKA) anchor protein 7 |
32209 |
0.24 |
chr12_121902175_121902326 | 0.24 |
KDM2B |
lysine (K)-specific demethylase 2B |
45259 |
0.13 |
chr10_5749983_5750134 | 0.24 |
RP11-336A10.2 |
|
6328 |
0.18 |
chr9_99481734_99481900 | 0.24 |
ZNF510 |
zinc finger protein 510 |
58511 |
0.12 |
chr12_116538771_116538922 | 0.24 |
ENSG00000200665 |
. |
18471 |
0.21 |
chr3_71447838_71447989 | 0.24 |
FOXP1 |
forkhead box P1 |
94002 |
0.08 |
chr11_12244895_12245157 | 0.24 |
RP11-265D17.2 |
|
39694 |
0.15 |
chr10_33622577_33623112 | 0.24 |
NRP1 |
neuropilin 1 |
466 |
0.87 |
chr6_5506877_5507119 | 0.24 |
RP1-232P20.1 |
|
48690 |
0.17 |
chr17_4248495_4248646 | 0.24 |
UBE2G1 |
ubiquitin-conjugating enzyme E2G 1 |
505 |
0.78 |
chrX_70317352_70317717 | 0.24 |
FOXO4 |
forkhead box O4 |
1155 |
0.33 |
chr2_122493823_122494052 | 0.24 |
NIFK |
nucleolar protein interacting with the FHA domain of MKI67 |
550 |
0.55 |
chr2_102974093_102974405 | 0.24 |
IL18R1 |
interleukin 18 receptor 1 |
1860 |
0.33 |
chr21_36384069_36384311 | 0.24 |
RUNX1 |
runt-related transcription factor 1 |
37272 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 0.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.1 | 0.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.2 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.2 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.1 | 0.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.3 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.3 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.1 | GO:1903224 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.1 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.1 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.2 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.0 | 0.5 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.1 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.1 | GO:0031223 | auditory behavior(GO:0031223) |
0.0 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.0 | 0.2 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.0 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.3 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.1 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 0.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.3 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.1 | GO:0043368 | positive T cell selection(GO:0043368) |
0.0 | 0.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.1 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.3 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.0 | 0.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.1 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.0 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.2 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.1 | GO:0015809 | arginine transport(GO:0015809) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.2 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.2 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.0 | 0.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.1 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.0 | 0.3 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.0 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.1 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.0 | 0.0 | GO:0052167 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) |
0.0 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.2 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.1 | GO:0031579 | membrane raft organization(GO:0031579) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.0 | 0.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.0 | 0.2 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.0 | 0.0 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.0 | 0.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.0 | 0.1 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.2 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.1 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.0 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.0 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.2 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.0 | 0.0 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.0 | 0.0 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.0 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.0 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.1 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.3 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.0 | 0.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.0 | GO:0090286 | nuclear matrix organization(GO:0043578) cytoskeletal anchoring at nuclear membrane(GO:0090286) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.3 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.1 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.0 | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
0.0 | 0.0 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.0 | 0.0 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.1 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.0 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.0 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.0 | 0.0 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.1 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 0.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.0 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.0 | 0.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.1 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.0 | 0.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.1 | GO:0051383 | kinetochore organization(GO:0051383) |
0.0 | 0.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.0 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.0 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.0 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.0 | 0.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.1 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.0 | 0.0 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.0 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.0 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.0 | 0.0 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.2 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.2 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.1 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.0 | GO:0031058 | positive regulation of histone modification(GO:0031058) |
0.0 | 0.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.1 | GO:0001776 | leukocyte homeostasis(GO:0001776) |
0.0 | 0.1 | GO:0030858 | positive regulation of epithelial cell differentiation(GO:0030858) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.0 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.0 | 0.0 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.1 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.0 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.1 | GO:0032400 | melanosome localization(GO:0032400) |
0.0 | 0.0 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.0 | 0.0 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.0 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.0 | 0.0 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.0 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.3 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.0 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.2 | GO:0048255 | RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
0.0 | 0.0 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.0 | 0.3 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.2 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 0.5 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 0.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.3 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.3 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.0 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.0 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.1 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.0 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.0 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.1 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.3 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.0 | GO:0032449 | CBM complex(GO:0032449) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 0.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.1 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.0 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.3 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.0 | GO:0034618 | nitric-oxide synthase activity(GO:0004517) arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.0 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.0 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.0 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.2 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.2 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.0 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.0 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.5 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.0 | 0.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.5 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.2 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |